Clinical Trial: Efficacy, Associated Factors, and Safety of Intravesical Bacillus CalmetteGuérin in Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Single-Center Ambidirectional Cohort Study (China)

Posted On: 2026-10-16

China, Oct. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy, Associated Factors, and Safety of Intravesical Bacillus CalmetteGuérin in Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Single-Center Ambidirectional Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134511

Registration Time: 2026/10/15

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347794

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy, Associated Factors, and Safety of Intravesical Bacillus CalmetteGuérin in Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Single-Center Ambidirectional Cohort Study (China)